Auricular Neuromodulation in Veterans With Fibromyalgia
NCT: NCT06415591 · RECRUITING
Brief Summary
PENFS (percutaneous electrical nerve field stimulation) is an FDA-cleared acupuncture-like therapy applied to the external ear targeting several cranial nerve branches including the auricular branch of the vagus nerve to improve pain, physical function, and reduce symptoms of opioid withdrawal. PENFS has been previously shown to provide improvements in fibromyalgia, a difficult to treat chronic pain syndrome, which correlate with changes observed using a special kind of MRI called resting state functional connectivity MRI (rs-fcMRI) that evaluates brain activity at rest. The goals of this study are to rigorously test the initial promising results of PENFS in a much larger group of Veterans suffering from fibromyalgia and to identify potential mechanisms of PENFS effects. Further developing non-pharmacologic therapies for pain can help to improve quality of life and function for those suffering from fibromyalgia and decrease reliance on opioids and other drugs that have numerous side effects for individuals suffering from chronic pain.
Frequently Asked Questions
What is Auricular Neuromodulation in Veterans With Fibromyalgia?
Auricular Neuromodulation in Veterans With Fibromyalgia is a clinical trial registered under NCT06415591. Current status: RECRUITING.
What is the status of NCT06415591?
The current status of NCT06415591 (Auricular Neuromodulation in Veterans With Fibromyalgia) is: RECRUITING.
When did Auricular Neuromodulation in Veterans With Fibromyalgia start?
Auricular Neuromodulation in Veterans With Fibromyalgia started on 2024-11-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.